CompletedNot Applicable

Monitoring the Hyperammonaemia:TOXicity of Drugs (AmmoTOX)

France2,700 participantsStarted 2019-05-01

Plain-language summary

Several drugs and chemotherapies seem to have an impact on the metabolic system. This study investigates reports of metabolic toxicities such as hyperammonemia, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Case reported in the WHO's pharmacovigilance database till 01/05/2019 Exclusion Criteria: * Chronology not compatible between the drug and the toxicity

What they're measuring

Metabolic toxicities (such as hyperammnemia) of drugs Identification and report of cases of metabolic toxicities associated with drugs.

Timeframe: to 01/05/2019

Trial details

NCT IDNCT03947034

SponsorGroupe Hospitalier Pitie-Salpetriere

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-05-30

View on ClinicalTrials.gov More Hyperammonemia trials